Neuralink, founded in 2016 by Elon Musk, didn’t seek permission for human trials from the FDA until early 2022 — and the agency rejected the application, citing safety risks Reuters exclusive from rachael_levy and marisaataylor
Musk has said his brain implant company, Neuralink, will make the paralyzed walk, the blind see and eventually turn people into cyborgs. But the firm still struggles to secure clinical-trial approval for the relatively modest goal of helping disabled people type.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Tesla Investor Day: Here's what you can expect from Elon Musk tomorrowWith conventional car makers catching up, Tesla is facing the heat in the EV market and now needs to unveil its strategy to stay ahead.
続きを読む »
Elon Musk is the richest person in the world againMusk’s net worth was some $187.1 billion as of Monday after markets closed, according to Bloomberg, just topping the $185.3 billion fortune of Bernard Arnault.
続きを読む »
Dogecoin (DOGE) Creator Will Not Work for Elon Musk: DetailsDOGE co-founder believes Elon Musk is cool, but they will not work together, here's why
続きを読む »
Tesla, Elon Musk sued over stock losses due to self-driving risks: reportTesla and Elon Musk sued by shareholders over Autopilot safety risks after a $38 billion drop in market value, report says
続きを読む »
Elon Musk Is Looking Into Creating an AI Alternative to ChatGPTUnhappy with OpenAI, which he co-founded, Musk is reportedly in talks with recently departed DeepMind AI researcher Igor Babuschkin.
続きを読む »